Laboratorios Richmond S.A.C.I.F. (BCBA:RICHD)

Argentina · Delayed Price · Currency is ARS · Price in USD

1.010

-0.090 (-8.18%)

Last updated: Oct 8, 2026, 2:02 PM BRT

Market Cap	118.92B +32.1%
Revenue (ttm)	114.02B -22.3%
Net Income	12.50B -35.8%
EPS	154.85 -35.8%
Shares Out	n/a
PE Ratio	9.53
Forward PE	n/a
Dividend	32.67 (2.13%)
Ex-Dividend Date	Jun 12, 2026

Volume	20
Open	1.010
Previous Close	1.100
Day's Range	1.010 - 1.010
52-Week Range	1.010 - 1.400
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About BCBA:RICHD

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnot... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1959

Employees 620

Stock Exchange Buenos Aires Stock Exchange

Ticker Symbol RICHD

Financial Performance

In 2025, BCBA:RICHD's revenue was 126.73 billion, an increase of 4.95% compared to the previous year's 120.75 billion. Earnings were 3.09 billion, a decrease of -90.16%.

Financial Statements